BMD 110 G DIN 02206099
Status: Marketed
Holder: PHIBRO ANIMAL HEALTH CORPORATION
Available to quote
Health Canada record
| Active ingredient(s) | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 110 G |
|---|---|
| Dosage form | Drug Premix |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 02-May-1997 |
| Current status date | 17-Jul-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Phibro Animal Health Ltd. — licence 3-002901, currently licensed, last inspection rating C (2026-06-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BACITRACIN (BACITRACIN METHYLENE DISALICYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02408317 | BACITRACIN MD | BIO AGRI MIX LP | Drug Premix | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 110 G | Marketed |
| 02512866 | BACITRACIN MD SOLUBLE | BIO AGRI MIX LP | Powder For Solution | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 440 MG | Approved |
| 01988751 | BMD 110 PREMIX 110GM/KG | A.L. LABORATORIES, INC. | Drug Premix | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 110 G | Cancelled Post Market |
| 02328135 | BMD SOLUBLE | PHIBRO ANIMAL HEALTH CORPORATION | Powder For Solution | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 440 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35680 | 2025-07-17 | New Drug Submission (NDS) | Administrative - Change in Product Ownership |
| 26056 | 2021-06-10 | Supplement to a New Drug Submission (SNDS) | NEW INDICATION : LAYING HENS |
| 22947 | 2019-11-26 | Supplement to a New Drug Submission (SNDS) | New indication: broiler chickens |
| 20380 | 2018-01-22 | Supplement to a New Drug Submission (SNDS) | REMOVAL OF SPECIES (TURKEYS) REMOVAL OF GROWTH PROMOTION CLAIMS. CHANGE TO PRESCRIPTION STATUS. LABELLING UPDATES |
| 15348 | 2014-02-26 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 3419 | 2003-08-14 | Supplement to a New Drug Submission (SNDS) | TO PROVIDE FOR THE CONCURRENT USE OF BMD 110G PREMIX, AT 55 PPM BACITRACIN FOR PREVENTION OF NECROTIC ENTERITIS, WITH MONTEBAN 70 PREMIX (ELANCO), AT 70 PPM NARASIN FOR THE PREVENTION OF COCCIDIOSIS, IN BROILER CHICKENS |
| 6270 | 2000-10-13 | New Drug Submission (NDS) | |
| 6968 | 1996-05-03 | New Drug Submission (NDS) |